Whether its roles in tumorigenicity or anti-apoptosis are related to ADCP remains unknown, and further investigation is needed to determine if IRX5 enhances the malignant capabilities of liver cancer cells by conferring resistance to ADCP. The gene discussed is IRX5; the disease is liver cancer.